Contrasting of Brainstorm Cell Therapeutics Inc. (BCLI) and Intec Pharma Ltd. (NASDAQ:NTEC)

Since Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) and Intec Pharma Ltd. (NASDAQ:NTEC) are part of the Biotechnology industry, they are influenced by compare. The influences particularly affect the dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation of both companies.

Earnings and Valuation

Demonstrates Brainstorm Cell Therapeutics Inc. and Intec Pharma Ltd. earnings per share, gross revenue and valuation.

Profitability

Table 2 provides the return on equity, return on assets and net margins of the two firms.

Analyst Recommendations

Brainstorm Cell Therapeutics Inc. and Intec Pharma Ltd. Ratings and Recommendations are available on the next table.

$9 is Brainstorm Cell Therapeutics Inc.’s consensus target price while its potential upside is 122.22%.

Institutional and Insider Ownership

Institutional investors owned 12.2% of Brainstorm Cell Therapeutics Inc. shares and 39.64% of Intec Pharma Ltd. shares. Insiders owned roughly 0.9% of Brainstorm Cell Therapeutics Inc.’s shares. Comparatively, Intec

... read more at: https://mcmonitor.com/2019/03/17/contrasting-of-brainstorm-cell-therapeutics-inc-bcli-and-intec-pharma-ltd-nasdaqntec/

by

Leave a Reply